FDA Calls Off Closed Hearing On Blood Substitute

Law360, New York (July 14, 2006, 12:00 AM EDT) -- Cowed by a consumer group lawsuit to open a closed-door meeting, the Food and Drug Administration decided to postpone Friday’s hearing to discuss the U.S. Navy’s proposition to proceed with a blood substitute trial.

The FDA said Thursday that the advisory panel meeting would be switched to an open meeting at a later date after consumer group Public Citizen’s Health Research Group filed a lawsuit Wednesday in the U.S. District Court for the District of Columbia demanding the agency either cancel the meeting or open it...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.